Quick Takeaways
- Nir Naor has 2 issuer positions tracked on this page.
- Estimated disclosed ownership value: $3,977,585.
- Recent insider filing activity is available below.
- Info
- Insider Ownership
Insider Trading & Ownership of Nir Naor
- Location
- New York, NY
- Summary
- The estimated net worth of Nir Naor is at least $3,977,585 dollars as of 06 Jan 2025. Nir Naor is the CFO of Axogen, Inc. and owns shares of Axogen, Inc. (AXGN) stock worth about $3.97M. Nir Naor is the Director of BRAINSTORM CELL THERAPEUTICS INC. and owns shares of BRAINSTORM CELL THERAPEUTICS INC. (BCLI) stock worth about $7.2K.
- Signature
- /s/ Nir Naor
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Nir Naor and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.
What Changed
- Largest disclosed position: Axogen, Inc. ($3,970,411).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of Nir Naor
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| AXGN | Axogen, Inc. | Cfo | $3,970,411 | 06 Jan 2025 | ||
| BCLI | BRAINSTORM CELL THERAPEUTICS INC. | Director | $7,174 | 01 Jan 2025 |
Insider Transactions Reported by Nir Naor:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.